Form 4: HCA Healthcare Director Receives Equity Award

Director Wayne Joseph Riley acquired 509 restricted share units as part of an annual director equity award.

Summary

• Director Wayne Joseph Riley was granted 509 restricted share units (RSUs) on April 28, 2026.
• The grant is part of the standard annual director equity compensation program.
• The total beneficial ownership for the director following this transaction is 15,029 shares of common stock.
• The RSUs vest on the earlier of the 2027 annual shareholders' meeting or the first anniversary of the grant date.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• None identified; this is a routine compensatory filing.

Risks

• None identified; this is a standard regulatory disclosure of director compensation.

Future Outlook

The restricted share units are scheduled to vest on the earlier of the 2027 annual shareholders' meeting or the first anniversary of the grant date, with delivery occurring upon the director's departure from the Board.

Industry Context

StockSavvy.ai notes that this filing represents standard corporate governance practice for large-cap healthcare providers, ensuring board members maintain a vested interest in company performance.

Comparison to Industry Standards

• The equity grant structure is consistent with standard director compensation practices among S&P 500 healthcare companies.

Stakeholder Impact

• Minimal impact; reflects standard director compensation alignment.

Next Steps

• Vesting of the 509 restricted share units in 2027.

Key Dates

Keywords

HCA Healthcare, Director Compensation, Form 4, Equity Award, Insider Transaction